Careers • News • Contact us •
Exploring new avenues to develop tomorrow’s medical knowledge through an approach that integrates basic and clinical research
Our research units are led by principal investigators who collaborate in a spirit of collegiality and with the vision of bridging the gap between research and patients. They train the next generation of scientists and are independent and creative minds who work tirelessly to improve health.
The brain is composed of billions of neurons that form a complex network. Inappropriate wiring of these neuronal connections has serious consequences for the sensory, motor and cognitive functions of the nervous system. Frédéric Charron’s research focuses on neural development and associated pathologies. He is a leader in Sonic hedgehog (Shh) signaling, having identified an axon pathfinding role for Shh and characterized a novel, non-canonical Shh signaling pathway. He has also characterized novel Shh receptors, a discovery that has fundamental implications for many pathologies, such as pediatric brain tumors.
During embryonic development, neurons extend axons, which are guided to their target via attractive and repulsive guidance molecules. We have demonstrated that Shh acts as a chemoattractive molecule for the axons of certain neurons in the spinal cord. One of the laboratory's objectives is to identify and characterize the components of the Shh signalling pathway in axonal guidance. In addition to helping understand the immense complexity underlying the wiring of the nervous system, this work will help to identify novel strategies to promote the proper guidance and rewiring of axons damaged by neurodegenerative diseases and brain or spinal cord injuries.
Shh is a multi-functional protein and, in addition to guiding axons, it is also a morphogen which stimulates the proliferation of granule cell precursors in the cerebellum. Abnormal regulation of Shh signaling in the cerebellum leads to medulloblastoma, a pediatric cancer of the brain that is the most common solid tumor in children. The research unit focuses on understanding how medulloblastoma forms, in particular which genes may promote or inhibit medulloblastoma tumorigenesis. This work may lead to the development of novel and more effective targeted therapies to treat medulloblastoma, and improve the survival and quality of life of affected patients.
Team |
|
Affiliations |
Other affiliations
|
Degrees and experience |
|
Axon guidance and nervous system circuit formation
One of the research unit's goals is to identify the genes involved in axon guidance by Shh and characterize how they function to guide axons. In parallel to these studies, members of the laboratory are using innovative genetic and live imaging approaches to characterize, with high spatio-temporal resolution, the role of axon guidance molecules, including Shh, in neural circuit formation.
Shh signaling and the pediatric brain tumor medulloblastoma
The research team is interested in other aspects of Shh signaling, including mechanisms underlying the reception of the Shh signal. In this regard, members have identified Boc, Cdon, and Gas1 as essential co-receptors for canonical Shh signaling. This breakthrough has fundamental implications for diseases that result from aberrant Shh signaling, including cancers and developmental disorders. Indeed, they have found that inhibition of Boc helps prevent the formation of medulloblastoma, a pediatric brain tumor. This highlights how abnormal regulation of Shh signaling in the cerebellum can lead to medulloblastoma. They have also discovered that evasion of cellular senescence is an important step in medulloblastoma progression. They are currently interested in the understanding what are the molecular and cellular changes that promote medulloblastoma development.
Approach: Cultivating cells or neural primary tissues in vitro
Because of its relative simplicity, this approach led to look at several molecular and cellular aspects of cell proliferation, cell migration and axon guidance both directly and in real time. To do so, members of the team use high-tech microscopy systems that allow living cells or tissues to be cultivated directly under the microscope. With this approach, they can also observe our samples continuously over several days, thus following their development in detail. They have also developed in the laboratory an axon guidance assay that allows us to measure the turning response of axons to defined gradients of guidance cues.
Approach: Mouse genetics as a model for the study of the molecular mechanisms of axon guidance or medulloblastoma formation.
For axon guidance, the generation of transgenic mice and the conditional knock-outs are particularly useful for the dissection of these mechanisms over time and within specific neural types. The research unit also has mouse models for medulloblastoma.
Approach: Studying the development of neural circuits in vivo in mice with the help of genetically-encoded fluorescent proteins.
This technique allows to characterize, with a high spatio-temporal resolution, the development of specific populations of neurons as well as their connection and integration to neural circuits.
Approach: Complementing the mouse genetics, we also utilise CRISPR-Cas9 and in utero electroporation to manipulate genes directly in the cerebellum during development.
To study axon guidance in embryos, members of the team can also manipulate gene expression by electroporation of siRNA into the spinal cord and culturing the embryos ex vivo, in an approach called whole embryo culture.
Press review |
|
Press review |
|
Grants |
Recognitions and honors |
|
© Montreal Clinical Research Institute, Année.All rights reserves. | Privacy policy | Terms of use | Web site by Agence Riposte